High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$296K
$296,999
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KPTI
S
Karyopharm Therapeutics Inc.
Abate Kristin
• Officer • Chief Accounting Officer
Discretionary Sell
2026-03-02
$5,260
|
||||||
| KPTI |
Karyopharm Therapeutics Inc.
|
Officer • Chief Accounting Officer
Discretionary Sell
|
2026-03-02 | $5,260 | S | Form 4 |
|
KPTI
S
Karyopharm Therapeutics Inc.
Cheng Sohanya Roshan
• Officer • EVP & Chief Commercial Officer
Discretionary Sell
2026-03-02
$43,321
|
||||||
| KPTI |
Karyopharm Therapeutics Inc.
|
Officer • EVP & Chief Commercial Officer
Discretionary Sell
|
2026-03-02 | $43,321 | S | Form 4 |
|
KPTI
S
Karyopharm Therapeutics Inc.
Mano Michael
• Officer • EVP, CLO&Secretary
Discretionary Sell
2026-03-02
$33,178
|
||||||
| KPTI |
Karyopharm Therapeutics Inc.
|
Officer • EVP, CLO&Secretary
Discretionary Sell
|
2026-03-02 | $33,178 | S | Form 4 |
| KPTI |
Karyopharm Therapeutics Inc.
|
CEO
Discretionary Sell
|
2026-03-02 | $116,311 | S | Form 4 |
|
KPTI
S
Karyopharm Therapeutics Inc.
Poulton Stuart
• Officer • EVP, Chief Development Officer
Discretionary Sell
2026-03-02
$47,998
|
||||||
| KPTI |
Karyopharm Therapeutics Inc.
|
Officer • EVP, Chief Development Officer
Discretionary Sell
|
2026-03-02 | $47,998 | S | Form 4 |
|
KPTI
S
Karyopharm Therapeutics Inc.
Rangwala Reshma
• Officer • EVP & Chief Medical Officer
Discretionary Sell
2026-03-02
$47,669
|
||||||
| KPTI |
Karyopharm Therapeutics Inc.
|
Officer • EVP & Chief Medical Officer
Discretionary Sell
|
2026-03-02 | $47,669 | S | Form 4 |
|
KPTI
S
Karyopharm Therapeutics Inc.
Poulton Stuart
• Officer • EVP, Chief Development Officer
Discretionary Sell
2026-02-17
$3,262
|
||||||
| KPTI |
Karyopharm Therapeutics Inc.
|
Officer • EVP, Chief Development Officer
Discretionary Sell
|
2026-02-17 | $3,262 | S | Form 4 |